Us Fda approves GSK's three-in-one drug inhaler for Copd

Us Fda approves GSK's three-in-one drug inhaler for Copd


GlaxoSmithKline Plc and Innoviva Inc said on Monday the U.S. Food and Drug Administration has approved their triple drug inhaler for treatment of chronic obstructive pulmonary disease . FILE PHOTO: A GlaxoSmithKline logo is seen outside one of its buildings in west London, February 6, 2008.



from Biotech News